Vaccination safety update
- PMID: 19471677
- PMCID: PMC2680557
- DOI: 10.3238/arztebl.2008.0590
Vaccination safety update
Abstract
Introduction: In Germany, a large number of biased reports against vaccination have recently been published in all of the news media, and particularly on the internet. This paper discusses the safety profile of modern vaccines and their continuous surveillance and shows why the current criticism of vaccination on safety grounds is unjustified.
Methods: The authors have performed a selective literature search to enable a proper distinction to be drawn between scientifically justified and unjustified reports on the potential adverse effects of vaccination.
Results: At present, the safety of a new vaccine must be demonstrated in large-scale clinical trials before the product is licensed. After licensing, the safety of new vaccines is constantly monitored, and the results of monitoring are published.
Discussion: An examination of these data reveals that the expressed doubts about the safety of vaccines are unjustified.
Keywords: safety; side effects; surveillance; unjustified scepticism about vaccines; vaccination.
Comment in
-
Long term side effects due to vaccination and pharmacovigilance.Dtsch Arztebl Int. 2009 Apr;106(14):248-9; author reply 249. doi: 10.3238/arztebl.2009.0248b. Epub 2009 Apr 3. Dtsch Arztebl Int. 2009. PMID: 19547642 Free PMC article. No abstract available.
References
-
- Ständige Impfkommission STIKO. Aktualisierte Hinweise für Ärzte zum Aufklärungsbedarf über mögliche unerwünschte Wirkungen bei Schutzimpfungen. Epidemiol Bull. 2007;25
-
- Stajich GV, Lopez GJ, Harry WW, Sexson WR. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr. 2000;136:679–681. - PubMed
-
- The European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. CPMP position paper on thiomersal - implementation of the warning statement relating to sensitisation. CPMP/2612/99. http://www.eudra.org/emea.html.
-
- Hernán MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. Neurology. 2005;63:838–842. - PubMed
-
- DeStefano F, Weintraub ES, Chen RT. Determining risk of multiple sclerosis after hepatitis B vaccine: time since vaccination and source of data. Pharmacoepidemiol Drug Saf. 2004;13 - PubMed
LinkOut - more resources
Full Text Sources
